Image pharmaphorum Editor News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology. News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives. News SMEs: the next generation of pharma News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t Load more results
News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology.
News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives.
News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.